Based on a leaked letter from overseas pharma industry bodies, a leading international daily in late July 2013 reported: “Big pharma mobilizing patients in battle over drugs trials data.” Some experts consider it as a poignant, if not a bizarre … Continue reading
Transparency in Drug Trial Data: Thwarted by Lobbyists or Embroiled in Controversy?
Reply